ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Targeted Drugs for Allergic Diseases Market Research Report 2025
Published Date: March 2025
|
Report Code: QYRE-Auto-35D18981
Home | Market Reports | Health| Pharmacy| Drugs & Medications
Global Targeted Drugs for Allergic Diseases Market Research Report 2025
BUY CHAPTERS

Global Targeted Drugs for Allergic Diseases Market Research Report 2025

Code: QYRE-Auto-35D18981
Report
March 2025
Pages:85
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Sanofi
AbbVie
Novartis
Incyte
Roche
Astrazeneca plc
GSK
Eli Lilly and Company
Amgen Inc
Pfizer Inc
LEO Pharma
TEVA
Otsuka Pharmaceutical
Mabpharm

Targeted Drugs for Allergic Diseases Market Size

The global market for Targeted Drugs for Allergic Diseases was valued at US$ 37150 million in the year 2024 and is projected to reach a revised size of US$ 104290 million by 2031, growing at a CAGR of 16.1% during the forecast period.

Targeted Drugs for Allergic Diseases Market

Targeted Drugs for Allergic Diseases Market

Anaphylaxis is an inappropriate reaction of the immune system to normal harmless substances. It generally has a rapid onset, strong reaction, and rapid subsidence. It has obvious genetic tendencies and individual differences. Currently, the prevalence of allergic diseases is increasing rapidly worldwide, affecting approximately 25% of the global population. Abnormalities in type 2 immune pathways are important factors in inducing allergic diseases. Type 2 immune pathway refers to an inflammatory pathway in which Th2 cells (T helper 2) play a key role, and various cytokines such as IL-4, IL-5, IL-13, and TSLP are involved. Depending on where the inflammatory reaction occurs, abnormal type 2 immune pathways can induce different allergic diseases, such as skin (atopic dermatitis, chronic spontaneous urticaria, etc.), respiratory tract (chronic sinusitis, asthma, chronic obstruction, etc.) lung disease, etc.), digestive tract (eosinophilic esophagitis), cardiovascular (eosinophilic granulomatous vasculitis), etc. Biological targeted drugs mainly reduce the inflammatory response and activity of immune cells by binding to targets such as specific regulatory factors in the type 2 immune pathway; Small molecule targeted drugs include JAK inhibitors and TYK2 inhibitors, which exert immunomodulatory effects by blocking the JAK/STAT pathway. Compared with traditional anti-allergic drugs, targeted drugs have better efficacy in severe or drug-resistant patients, and the drugs themselves are safer, and have gradually become the mainstream trend in the development of anti-allergic drugs.
Global key players of Targeted Drugs for Allergic Diseases include Sanofi, AbbVie, Novartis, Incyte, Roche, etc. The top five players hold a share over 76%. North America is the largest market, and has a share about 68%, followed by Europe with share 18%. In terms of product type, IL-4R is the largest segment, occupied for a share of 37%. In terms of application, Asthma has a share about 35 percent.
This report aims to provide a comprehensive presentation of the global market for Targeted Drugs for Allergic Diseases, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Targeted Drugs for Allergic Diseases.
The Targeted Drugs for Allergic Diseases market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Targeted Drugs for Allergic Diseases market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Targeted Drugs for Allergic Diseases companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Targeted Drugs for Allergic Diseases Market Report

Report Metric Details
Report Name Targeted Drugs for Allergic Diseases Market
Accounted market size in year US$ 37150 million
Forecasted market size in 2031 US$ 104290 million
CAGR 16.1%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
  • IL-4R
  • TSLP
  • IL-5
  • JAK
  • IgE
  • IL-13
  • Others
Segment by Application
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Sanofi, AbbVie, Novartis, Incyte, Roche, AstraZeneca, GSK, Eli Lilly and Company, Amgen, Pfizer, Leo Pharma, Teva, Otsuka Pharmaceutical, Mabpharm
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Targeted Drugs for Allergic Diseases company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Targeted Drugs for Allergic Diseases Market growing?

Ans: The Targeted Drugs for Allergic Diseases Market witnessing a CAGR of 16.1% during the forecast period 2025-2031.

What is the Targeted Drugs for Allergic Diseases Market size in 2031?

Ans: The Targeted Drugs for Allergic Diseases Market size in 2031 will be US$ 104290 million.

What is the market share of major companies in Targeted Drugs for Allergic Diseases Market?

Ans: The top five players hold a share over 76%.

What is the Targeted Drugs for Allergic Diseases Market share by type?

Ans: In terms of product type, IL-4R is the largest segment, occupied for a share of 37%.

Who are the main players in the Targeted Drugs for Allergic Diseases Market report?

Ans: The main players in the Targeted Drugs for Allergic Diseases Market are Sanofi, AbbVie, Novartis, Incyte, Roche, AstraZeneca, GSK, Eli Lilly and Company, Amgen, Pfizer, Leo Pharma, Teva, Otsuka Pharmaceutical, Mabpharm

What are the Application segmentation covered in the Targeted Drugs for Allergic Diseases Market report?

Ans: The Applications covered in the Targeted Drugs for Allergic Diseases Market report are Atopic Dermatitis, Asthma, Chronic Sinusitis with Nasal Polyps, Chronic Obstructive Pulmonary Disease, Others

What are the Type segmentation covered in the Targeted Drugs for Allergic Diseases Market report?

Ans: The Types covered in the Targeted Drugs for Allergic Diseases Market report are IL-4R, TSLP, IL-5, JAK, IgE, IL-13, Others

Recommended Reports

Allergy Drug Markets

Asthma Therapeutics

Allergy Diagnostics & Immuno

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Targeted Drugs for Allergic Diseases Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 IL-4R
1.2.3 TSLP
1.2.4 IL-5
1.2.5 JAK
1.2.6 IgE
1.2.7 IL-13
1.2.8 Others
1.3 Market by Application
1.3.1 Global Targeted Drugs for Allergic Diseases Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Atopic Dermatitis
1.3.3 Asthma
1.3.4 Chronic Sinusitis with Nasal Polyps
1.3.5 Chronic Obstructive Pulmonary Disease
1.3.6 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Targeted Drugs for Allergic Diseases Market Perspective (2020-2031)
2.2 Global Targeted Drugs for Allergic Diseases Growth Trends by Region
2.2.1 Global Targeted Drugs for Allergic Diseases Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Targeted Drugs for Allergic Diseases Historic Market Size by Region (2020-2025)
2.2.3 Targeted Drugs for Allergic Diseases Forecasted Market Size by Region (2026-2031)
2.3 Targeted Drugs for Allergic Diseases Market Dynamics
2.3.1 Targeted Drugs for Allergic Diseases Industry Trends
2.3.2 Targeted Drugs for Allergic Diseases Market Drivers
2.3.3 Targeted Drugs for Allergic Diseases Market Challenges
2.3.4 Targeted Drugs for Allergic Diseases Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Targeted Drugs for Allergic Diseases Players by Revenue
3.1.1 Global Top Targeted Drugs for Allergic Diseases Players by Revenue (2020-2025)
3.1.2 Global Targeted Drugs for Allergic Diseases Revenue Market Share by Players (2020-2025)
3.2 Global Targeted Drugs for Allergic Diseases Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Targeted Drugs for Allergic Diseases Revenue
3.4 Global Targeted Drugs for Allergic Diseases Market Concentration Ratio
3.4.1 Global Targeted Drugs for Allergic Diseases Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Targeted Drugs for Allergic Diseases Revenue in 2024
3.5 Global Key Players of Targeted Drugs for Allergic Diseases Head office and Area Served
3.6 Global Key Players of Targeted Drugs for Allergic Diseases, Product and Application
3.7 Global Key Players of Targeted Drugs for Allergic Diseases, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Targeted Drugs for Allergic Diseases Breakdown Data by Type
4.1 Global Targeted Drugs for Allergic Diseases Historic Market Size by Type (2020-2025)
4.2 Global Targeted Drugs for Allergic Diseases Forecasted Market Size by Type (2026-2031)
5 Targeted Drugs for Allergic Diseases Breakdown Data by Application
5.1 Global Targeted Drugs for Allergic Diseases Historic Market Size by Application (2020-2025)
5.2 Global Targeted Drugs for Allergic Diseases Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Targeted Drugs for Allergic Diseases Market Size (2020-2031)
6.2 North America Targeted Drugs for Allergic Diseases Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Targeted Drugs for Allergic Diseases Market Size by Country (2020-2025)
6.4 North America Targeted Drugs for Allergic Diseases Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Targeted Drugs for Allergic Diseases Market Size (2020-2031)
7.2 Europe Targeted Drugs for Allergic Diseases Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Targeted Drugs for Allergic Diseases Market Size by Country (2020-2025)
7.4 Europe Targeted Drugs for Allergic Diseases Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Targeted Drugs for Allergic Diseases Market Size (2020-2031)
8.2 Asia-Pacific Targeted Drugs for Allergic Diseases Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Targeted Drugs for Allergic Diseases Market Size by Region (2020-2025)
8.4 Asia-Pacific Targeted Drugs for Allergic Diseases Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Targeted Drugs for Allergic Diseases Market Size (2020-2031)
9.2 Latin America Targeted Drugs for Allergic Diseases Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Targeted Drugs for Allergic Diseases Market Size by Country (2020-2025)
9.4 Latin America Targeted Drugs for Allergic Diseases Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Targeted Drugs for Allergic Diseases Market Size (2020-2031)
10.2 Middle East & Africa Targeted Drugs for Allergic Diseases Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Targeted Drugs for Allergic Diseases Market Size by Country (2020-2025)
10.4 Middle East & Africa Targeted Drugs for Allergic Diseases Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Sanofi
11.1.1 Sanofi Company Details
11.1.2 Sanofi Business Overview
11.1.3 Sanofi Targeted Drugs for Allergic Diseases Introduction
11.1.4 Sanofi Revenue in Targeted Drugs for Allergic Diseases Business (2020-2025)
11.1.5 Sanofi Recent Development
11.2 AbbVie
11.2.1 AbbVie Company Details
11.2.2 AbbVie Business Overview
11.2.3 AbbVie Targeted Drugs for Allergic Diseases Introduction
11.2.4 AbbVie Revenue in Targeted Drugs for Allergic Diseases Business (2020-2025)
11.2.5 AbbVie Recent Development
11.3 Novartis
11.3.1 Novartis Company Details
11.3.2 Novartis Business Overview
11.3.3 Novartis Targeted Drugs for Allergic Diseases Introduction
11.3.4 Novartis Revenue in Targeted Drugs for Allergic Diseases Business (2020-2025)
11.3.5 Novartis Recent Development
11.4 Incyte
11.4.1 Incyte Company Details
11.4.2 Incyte Business Overview
11.4.3 Incyte Targeted Drugs for Allergic Diseases Introduction
11.4.4 Incyte Revenue in Targeted Drugs for Allergic Diseases Business (2020-2025)
11.4.5 Incyte Recent Development
11.5 Roche
11.5.1 Roche Company Details
11.5.2 Roche Business Overview
11.5.3 Roche Targeted Drugs for Allergic Diseases Introduction
11.5.4 Roche Revenue in Targeted Drugs for Allergic Diseases Business (2020-2025)
11.5.5 Roche Recent Development
11.6 AstraZeneca
11.6.1 AstraZeneca Company Details
11.6.2 AstraZeneca Business Overview
11.6.3 AstraZeneca Targeted Drugs for Allergic Diseases Introduction
11.6.4 AstraZeneca Revenue in Targeted Drugs for Allergic Diseases Business (2020-2025)
11.6.5 AstraZeneca Recent Development
11.7 GSK
11.7.1 GSK Company Details
11.7.2 GSK Business Overview
11.7.3 GSK Targeted Drugs for Allergic Diseases Introduction
11.7.4 GSK Revenue in Targeted Drugs for Allergic Diseases Business (2020-2025)
11.7.5 GSK Recent Development
11.8 Eli Lilly and Company
11.8.1 Eli Lilly and Company Company Details
11.8.2 Eli Lilly and Company Business Overview
11.8.3 Eli Lilly and Company Targeted Drugs for Allergic Diseases Introduction
11.8.4 Eli Lilly and Company Revenue in Targeted Drugs for Allergic Diseases Business (2020-2025)
11.8.5 Eli Lilly and Company Recent Development
11.9 Amgen
11.9.1 Amgen Company Details
11.9.2 Amgen Business Overview
11.9.3 Amgen Targeted Drugs for Allergic Diseases Introduction
11.9.4 Amgen Revenue in Targeted Drugs for Allergic Diseases Business (2020-2025)
11.9.5 Amgen Recent Development
11.10 Pfizer
11.10.1 Pfizer Company Details
11.10.2 Pfizer Business Overview
11.10.3 Pfizer Targeted Drugs for Allergic Diseases Introduction
11.10.4 Pfizer Revenue in Targeted Drugs for Allergic Diseases Business (2020-2025)
11.10.5 Pfizer Recent Development
11.11 Leo Pharma
11.11.1 Leo Pharma Company Details
11.11.2 Leo Pharma Business Overview
11.11.3 Leo Pharma Targeted Drugs for Allergic Diseases Introduction
11.11.4 Leo Pharma Revenue in Targeted Drugs for Allergic Diseases Business (2020-2025)
11.11.5 Leo Pharma Recent Development
11.12 Teva
11.12.1 Teva Company Details
11.12.2 Teva Business Overview
11.12.3 Teva Targeted Drugs for Allergic Diseases Introduction
11.12.4 Teva Revenue in Targeted Drugs for Allergic Diseases Business (2020-2025)
11.12.5 Teva Recent Development
11.13 Otsuka Pharmaceutical
11.13.1 Otsuka Pharmaceutical Company Details
11.13.2 Otsuka Pharmaceutical Business Overview
11.13.3 Otsuka Pharmaceutical Targeted Drugs for Allergic Diseases Introduction
11.13.4 Otsuka Pharmaceutical Revenue in Targeted Drugs for Allergic Diseases Business (2020-2025)
11.13.5 Otsuka Pharmaceutical Recent Development
11.14 Mabpharm
11.14.1 Mabpharm Company Details
11.14.2 Mabpharm Business Overview
11.14.3 Mabpharm Targeted Drugs for Allergic Diseases Introduction
11.14.4 Mabpharm Revenue in Targeted Drugs for Allergic Diseases Business (2020-2025)
11.14.5 Mabpharm Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
Sanofi
AbbVie
Novartis
Incyte
Roche
Astrazeneca plc
GSK
Eli Lilly and Company
Amgen Inc
Pfizer Inc
LEO Pharma
TEVA
Otsuka Pharmaceutical
Mabpharm
List of Tables
 Table 1. Global Targeted Drugs for Allergic Diseases Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of IL-4R
 Table 3. Key Players of TSLP
 Table 4. Key Players of IL-5
 Table 5. Key Players of JAK
 Table 6. Key Players of IgE
 Table 7. Key Players of IL-13
 Table 8. Key Players of Others
 Table 9. Global Targeted Drugs for Allergic Diseases Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 10. Global Targeted Drugs for Allergic Diseases Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 11. Global Targeted Drugs for Allergic Diseases Market Size by Region (2020-2025) & (US$ Million)
 Table 12. Global Targeted Drugs for Allergic Diseases Market Share by Region (2020-2025)
 Table 13. Global Targeted Drugs for Allergic Diseases Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 14. Global Targeted Drugs for Allergic Diseases Market Share by Region (2026-2031)
 Table 15. Targeted Drugs for Allergic Diseases Market Trends
 Table 16. Targeted Drugs for Allergic Diseases Market Drivers
 Table 17. Targeted Drugs for Allergic Diseases Market Challenges
 Table 18. Targeted Drugs for Allergic Diseases Market Restraints
 Table 19. Global Targeted Drugs for Allergic Diseases Revenue by Players (2020-2025) & (US$ Million)
 Table 20. Global Targeted Drugs for Allergic Diseases Market Share by Players (2020-2025)
 Table 21. Global Top Targeted Drugs for Allergic Diseases Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Targeted Drugs for Allergic Diseases as of 2024)
 Table 22. Ranking of Global Top Targeted Drugs for Allergic Diseases Companies by Revenue (US$ Million) in 2024
 Table 23. Global 5 Largest Players Market Share by Targeted Drugs for Allergic Diseases Revenue (CR5 and HHI) & (2020-2025)
 Table 24. Global Key Players of Targeted Drugs for Allergic Diseases, Headquarters and Area Served
 Table 25. Global Key Players of Targeted Drugs for Allergic Diseases, Product and Application
 Table 26. Global Key Players of Targeted Drugs for Allergic Diseases, Date of Enter into This Industry
 Table 27. Mergers & Acquisitions, Expansion Plans
 Table 28. Global Targeted Drugs for Allergic Diseases Market Size by Type (2020-2025) & (US$ Million)
 Table 29. Global Targeted Drugs for Allergic Diseases Revenue Market Share by Type (2020-2025)
 Table 30. Global Targeted Drugs for Allergic Diseases Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 31. Global Targeted Drugs for Allergic Diseases Revenue Market Share by Type (2026-2031)
 Table 32. Global Targeted Drugs for Allergic Diseases Market Size by Application (2020-2025) & (US$ Million)
 Table 33. Global Targeted Drugs for Allergic Diseases Revenue Market Share by Application (2020-2025)
 Table 34. Global Targeted Drugs for Allergic Diseases Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 35. Global Targeted Drugs for Allergic Diseases Revenue Market Share by Application (2026-2031)
 Table 36. North America Targeted Drugs for Allergic Diseases Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 37. North America Targeted Drugs for Allergic Diseases Market Size by Country (2020-2025) & (US$ Million)
 Table 38. North America Targeted Drugs for Allergic Diseases Market Size by Country (2026-2031) & (US$ Million)
 Table 39. Europe Targeted Drugs for Allergic Diseases Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 40. Europe Targeted Drugs for Allergic Diseases Market Size by Country (2020-2025) & (US$ Million)
 Table 41. Europe Targeted Drugs for Allergic Diseases Market Size by Country (2026-2031) & (US$ Million)
 Table 42. Asia-Pacific Targeted Drugs for Allergic Diseases Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 43. Asia-Pacific Targeted Drugs for Allergic Diseases Market Size by Region (2020-2025) & (US$ Million)
 Table 44. Asia-Pacific Targeted Drugs for Allergic Diseases Market Size by Region (2026-2031) & (US$ Million)
 Table 45. Latin America Targeted Drugs for Allergic Diseases Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 46. Latin America Targeted Drugs for Allergic Diseases Market Size by Country (2020-2025) & (US$ Million)
 Table 47. Latin America Targeted Drugs for Allergic Diseases Market Size by Country (2026-2031) & (US$ Million)
 Table 48. Middle East & Africa Targeted Drugs for Allergic Diseases Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 49. Middle East & Africa Targeted Drugs for Allergic Diseases Market Size by Country (2020-2025) & (US$ Million)
 Table 50. Middle East & Africa Targeted Drugs for Allergic Diseases Market Size by Country (2026-2031) & (US$ Million)
 Table 51. Sanofi Company Details
 Table 52. Sanofi Business Overview
 Table 53. Sanofi Targeted Drugs for Allergic Diseases Product
 Table 54. Sanofi Revenue in Targeted Drugs for Allergic Diseases Business (2020-2025) & (US$ Million)
 Table 55. Sanofi Recent Development
 Table 56. AbbVie Company Details
 Table 57. AbbVie Business Overview
 Table 58. AbbVie Targeted Drugs for Allergic Diseases Product
 Table 59. AbbVie Revenue in Targeted Drugs for Allergic Diseases Business (2020-2025) & (US$ Million)
 Table 60. AbbVie Recent Development
 Table 61. Novartis Company Details
 Table 62. Novartis Business Overview
 Table 63. Novartis Targeted Drugs for Allergic Diseases Product
 Table 64. Novartis Revenue in Targeted Drugs for Allergic Diseases Business (2020-2025) & (US$ Million)
 Table 65. Novartis Recent Development
 Table 66. Incyte Company Details
 Table 67. Incyte Business Overview
 Table 68. Incyte Targeted Drugs for Allergic Diseases Product
 Table 69. Incyte Revenue in Targeted Drugs for Allergic Diseases Business (2020-2025) & (US$ Million)
 Table 70. Incyte Recent Development
 Table 71. Roche Company Details
 Table 72. Roche Business Overview
 Table 73. Roche Targeted Drugs for Allergic Diseases Product
 Table 74. Roche Revenue in Targeted Drugs for Allergic Diseases Business (2020-2025) & (US$ Million)
 Table 75. Roche Recent Development
 Table 76. AstraZeneca Company Details
 Table 77. AstraZeneca Business Overview
 Table 78. AstraZeneca Targeted Drugs for Allergic Diseases Product
 Table 79. AstraZeneca Revenue in Targeted Drugs for Allergic Diseases Business (2020-2025) & (US$ Million)
 Table 80. AstraZeneca Recent Development
 Table 81. GSK Company Details
 Table 82. GSK Business Overview
 Table 83. GSK Targeted Drugs for Allergic Diseases Product
 Table 84. GSK Revenue in Targeted Drugs for Allergic Diseases Business (2020-2025) & (US$ Million)
 Table 85. GSK Recent Development
 Table 86. Eli Lilly and Company Company Details
 Table 87. Eli Lilly and Company Business Overview
 Table 88. Eli Lilly and Company Targeted Drugs for Allergic Diseases Product
 Table 89. Eli Lilly and Company Revenue in Targeted Drugs for Allergic Diseases Business (2020-2025) & (US$ Million)
 Table 90. Eli Lilly and Company Recent Development
 Table 91. Amgen Company Details
 Table 92. Amgen Business Overview
 Table 93. Amgen Targeted Drugs for Allergic Diseases Product
 Table 94. Amgen Revenue in Targeted Drugs for Allergic Diseases Business (2020-2025) & (US$ Million)
 Table 95. Amgen Recent Development
 Table 96. Pfizer Company Details
 Table 97. Pfizer Business Overview
 Table 98. Pfizer Targeted Drugs for Allergic Diseases Product
 Table 99. Pfizer Revenue in Targeted Drugs for Allergic Diseases Business (2020-2025) & (US$ Million)
 Table 100. Pfizer Recent Development
 Table 101. Leo Pharma Company Details
 Table 102. Leo Pharma Business Overview
 Table 103. Leo Pharma Targeted Drugs for Allergic Diseases Product
 Table 104. Leo Pharma Revenue in Targeted Drugs for Allergic Diseases Business (2020-2025) & (US$ Million)
 Table 105. Leo Pharma Recent Development
 Table 106. Teva Company Details
 Table 107. Teva Business Overview
 Table 108. Teva Targeted Drugs for Allergic Diseases Product
 Table 109. Teva Revenue in Targeted Drugs for Allergic Diseases Business (2020-2025) & (US$ Million)
 Table 110. Teva Recent Development
 Table 111. Otsuka Pharmaceutical Company Details
 Table 112. Otsuka Pharmaceutical Business Overview
 Table 113. Otsuka Pharmaceutical Targeted Drugs for Allergic Diseases Product
 Table 114. Otsuka Pharmaceutical Revenue in Targeted Drugs for Allergic Diseases Business (2020-2025) & (US$ Million)
 Table 115. Otsuka Pharmaceutical Recent Development
 Table 116. Mabpharm Company Details
 Table 117. Mabpharm Business Overview
 Table 118. Mabpharm Targeted Drugs for Allergic Diseases Product
 Table 119. Mabpharm Revenue in Targeted Drugs for Allergic Diseases Business (2020-2025) & (US$ Million)
 Table 120. Mabpharm Recent Development
 Table 121. Research Programs/Design for This Report
 Table 122. Key Data Information from Secondary Sources
 Table 123. Key Data Information from Primary Sources
 Table 124. Authors List of This Report


List of Figures
 Figure 1. Targeted Drugs for Allergic Diseases Picture
 Figure 2. Global Targeted Drugs for Allergic Diseases Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Targeted Drugs for Allergic Diseases Market Share by Type: 2024 VS 2031
 Figure 4. IL-4R Features
 Figure 5. TSLP Features
 Figure 6. IL-5 Features
 Figure 7. JAK Features
 Figure 8. IgE Features
 Figure 9. IL-13 Features
 Figure 10. Others Features
 Figure 11. Global Targeted Drugs for Allergic Diseases Market Size by Application (2020-2031) & (US$ Million)
 Figure 12. Global Targeted Drugs for Allergic Diseases Market Share by Application: 2024 VS 2031
 Figure 13. Atopic Dermatitis Case Studies
 Figure 14. Asthma Case Studies
 Figure 15. Chronic Sinusitis with Nasal Polyps Case Studies
 Figure 16. Chronic Obstructive Pulmonary Disease Case Studies
 Figure 17. Others Case Studies
 Figure 18. Targeted Drugs for Allergic Diseases Report Years Considered
 Figure 19. Global Targeted Drugs for Allergic Diseases Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 20. Global Targeted Drugs for Allergic Diseases Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 21. Global Targeted Drugs for Allergic Diseases Market Share by Region: 2024 VS 2031
 Figure 22. Global Targeted Drugs for Allergic Diseases Market Share by Players in 2024
 Figure 23. Global Top Targeted Drugs for Allergic Diseases Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Targeted Drugs for Allergic Diseases as of 2024)
 Figure 24. The Top 10 and 5 Players Market Share by Targeted Drugs for Allergic Diseases Revenue in 2024
 Figure 25. North America Targeted Drugs for Allergic Diseases Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. North America Targeted Drugs for Allergic Diseases Market Share by Country (2020-2031)
 Figure 27. United States Targeted Drugs for Allergic Diseases Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. Canada Targeted Drugs for Allergic Diseases Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. Europe Targeted Drugs for Allergic Diseases Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Europe Targeted Drugs for Allergic Diseases Market Share by Country (2020-2031)
 Figure 31. Germany Targeted Drugs for Allergic Diseases Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. France Targeted Drugs for Allergic Diseases Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. U.K. Targeted Drugs for Allergic Diseases Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. Italy Targeted Drugs for Allergic Diseases Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. Russia Targeted Drugs for Allergic Diseases Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. Nordic Countries Targeted Drugs for Allergic Diseases Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. Asia-Pacific Targeted Drugs for Allergic Diseases Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. Asia-Pacific Targeted Drugs for Allergic Diseases Market Share by Region (2020-2031)
 Figure 39. China Targeted Drugs for Allergic Diseases Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. Japan Targeted Drugs for Allergic Diseases Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. South Korea Targeted Drugs for Allergic Diseases Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Southeast Asia Targeted Drugs for Allergic Diseases Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. India Targeted Drugs for Allergic Diseases Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Australia Targeted Drugs for Allergic Diseases Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. Latin America Targeted Drugs for Allergic Diseases Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. Latin America Targeted Drugs for Allergic Diseases Market Share by Country (2020-2031)
 Figure 47. Mexico Targeted Drugs for Allergic Diseases Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 48. Brazil Targeted Drugs for Allergic Diseases Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 49. Middle East & Africa Targeted Drugs for Allergic Diseases Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 50. Middle East & Africa Targeted Drugs for Allergic Diseases Market Share by Country (2020-2031)
 Figure 51. Turkey Targeted Drugs for Allergic Diseases Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 52. Saudi Arabia Targeted Drugs for Allergic Diseases Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 53. UAE Targeted Drugs for Allergic Diseases Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 54. Sanofi Revenue Growth Rate in Targeted Drugs for Allergic Diseases Business (2020-2025)
 Figure 55. AbbVie Revenue Growth Rate in Targeted Drugs for Allergic Diseases Business (2020-2025)
 Figure 56. Novartis Revenue Growth Rate in Targeted Drugs for Allergic Diseases Business (2020-2025)
 Figure 57. Incyte Revenue Growth Rate in Targeted Drugs for Allergic Diseases Business (2020-2025)
 Figure 58. Roche Revenue Growth Rate in Targeted Drugs for Allergic Diseases Business (2020-2025)
 Figure 59. AstraZeneca Revenue Growth Rate in Targeted Drugs for Allergic Diseases Business (2020-2025)
 Figure 60. GSK Revenue Growth Rate in Targeted Drugs for Allergic Diseases Business (2020-2025)
 Figure 61. Eli Lilly and Company Revenue Growth Rate in Targeted Drugs for Allergic Diseases Business (2020-2025)
 Figure 62. Amgen Revenue Growth Rate in Targeted Drugs for Allergic Diseases Business (2020-2025)
 Figure 63. Pfizer Revenue Growth Rate in Targeted Drugs for Allergic Diseases Business (2020-2025)
 Figure 64. Leo Pharma Revenue Growth Rate in Targeted Drugs for Allergic Diseases Business (2020-2025)
 Figure 65. Teva Revenue Growth Rate in Targeted Drugs for Allergic Diseases Business (2020-2025)
 Figure 66. Otsuka Pharmaceutical Revenue Growth Rate in Targeted Drugs for Allergic Diseases Business (2020-2025)
 Figure 67. Mabpharm Revenue Growth Rate in Targeted Drugs for Allergic Diseases Business (2020-2025)
 Figure 68. Bottom-up and Top-down Approaches for This Report
 Figure 69. Data Triangulation
 Figure 70. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Accenture

SIMILAR REPORTS

Global Type 2 Inflammation Targeting Drugs Market Research Report 2024
Global Human Allergy Treatment Market Research Report 2025
Global Food Allergy Treatment Market Research Report 2024
Global Anaphylaxis Treatment Market Research Report 2024
Global Food Allergy Diagnostics and Therapeutics Market Research Report 2024
Global Asthma Therapeutics Market Research Report 2025
Global Small Molecule Targeted Drugs for Allergic Diseases Market Research Report 2024
Global Allergic Asthma Therapeutics Market Research Report 2025
Global Immune System Allergy Treatment Market Research Report 2025
Global Drugs to Treat Allergic Diseases Market Research Report 2024
Global Allergy Rhinitis Drug Market Research Report 2025
Global Anti allergic Drugs Market Research Report 2025
Global Peanut Allergy Therapeutics Market Research Report 2024
Generic Allergy Medicine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Allergy Rhinitis Drugs Market Research Report 2024
Hay Fever and Allergic Rhinitis Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Allergy Diagnostics And Treatment Market
Global Cat Allergy Medicine Market Research Report 2024
Allergic Rhinitis Medication Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Anti Allergy Medicine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions